| __timestamp | Jazz Pharmaceuticals plc | Johnson & Johnson |
|---|---|---|
| Wednesday, January 1, 2014 | 85181000 | 8494000000 |
| Thursday, January 1, 2015 | 135253000 | 9046000000 |
| Friday, January 1, 2016 | 162297000 | 9095000000 |
| Sunday, January 1, 2017 | 198442000 | 10554000000 |
| Monday, January 1, 2018 | 226616000 | 10775000000 |
| Tuesday, January 1, 2019 | 299726000 | 11355000000 |
| Wednesday, January 1, 2020 | 335375000 | 12340000000 |
| Friday, January 1, 2021 | 505748000 | 14277000000 |
| Saturday, January 1, 2022 | 590453000 | 14135000000 |
| Sunday, January 1, 2023 | 849658000 | 15048000000 |
| Monday, January 1, 2024 | 17232000000 |
Unleashing insights
In the ever-evolving pharmaceutical landscape, research and development (R&D) is the lifeblood of innovation. Over the past decade, Johnson & Johnson and Jazz Pharmaceuticals plc have demonstrated contrasting strategies in their R&D investments. From 2014 to 2023, Johnson & Johnson consistently allocated substantial resources, with a peak in 2023, investing nearly 77% more than in 2014. This commitment underscores their dedication to pioneering healthcare solutions. Meanwhile, Jazz Pharmaceuticals plc, though smaller in scale, has shown remarkable growth in R&D spending, increasing by almost tenfold over the same period. This surge highlights their aggressive pursuit of niche markets and innovative therapies. As these companies continue to navigate the complexities of the pharmaceutical industry, their R&D strategies will undoubtedly shape the future of healthcare.
Johnson & Johnson vs Merck & Co., Inc.: Strategic Focus on R&D Spending
R&D Spending Showdown: Johnson & Johnson vs Bristol-Myers Squibb Company
Research and Development Investment: Johnson & Johnson vs Pfizer Inc.
Who Prioritizes Innovation? R&D Spending Compared for Johnson & Johnson and Zoetis Inc.
Who Optimizes SG&A Costs Better? Johnson & Johnson or Jazz Pharmaceuticals plc
Research and Development Investment: Johnson & Johnson vs Catalyst Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Johnson & Johnson and Celldex Therapeutics, Inc.
Research and Development Investment: BioMarin Pharmaceutical Inc. vs Jazz Pharmaceuticals plc
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Alpine Immune Sciences, Inc.
R&D Insights: How Jazz Pharmaceuticals plc and Ultragenyx Pharmaceutical Inc. Allocate Funds
Comparing Innovation Spending: Jazz Pharmaceuticals plc and MorphoSys AG
Research and Development Investment: Jazz Pharmaceuticals plc vs HUTCHMED (China) Limited